Pharma industry bullish on complex generics and biosimilars
While top industry leaders are optimistic about the growth, they expect the special incentives and regulatory streamlining from the government’s side
While top industry leaders are optimistic about the growth, they expect the special incentives and regulatory streamlining from the government’s side
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
Indian Chemical News, an online news media covering Pharma, Chemical and Petrochemical sector is organizing an E-conference on “India's Pharma Industry Outlook 2021” on 12th February, 2021 from 3:00 PM – 4:30 PM.
The DREAM-ND Phase III trial has now enrolled 588 CKD patients not-on-dialysis.
Subscribe To Our Newsletter & Stay Updated